Bryn Mawr Trust CO Edwards Lifesciences Corp Transaction History

Bryn Mawr Trust CO

$2.54 Billion
Q2 2024

A detailed history of Bryn Mawr Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 3,686 shares of EW stock, worth $252,601. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,686

Previous 3,359 9.74%

Holding current value

$252,601

Previous $320,000 6.25%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$84.3 - $94.31 $27,566 - $30,839	327 Added 9.74%	3,686 $340,000
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $25,751 - $33,923	-355 Reduced 9.56%	3,359 $320,000
Q3 2023 Nov 15, 2023	BUY	$69.28 - $93.38 $8,937 - $12,046	129 Added 3.6%	3,714 $257,000
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $3,935 - $4,479	-53 Reduced 1.46%	3,585 $296,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $4,365 - $5,686	53 Added 1.48%	3,638 $300,000
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $1,124 - $1,667	-13 Reduced 0.36%	3,585 $341,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $209,323 - $263,482	-2,053 Reduced 36.33%	3,598 $424,000
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $229,546 - $282,007	-2,158 Reduced 27.63%	5,651 $732,000
Q3 2021 Oct 26, 2021	SELL	$102.91 - $122.75 $42,398 - $50,573	-412 Reduced 5.01%	7,809 $884,000
Q2 2021 Jul 29, 2021	SELL	$83.84 - $104.76 $4,192 - $5,238	-50 Reduced 0.6%	8,221 $852,000
Q1 2021 Apr 23, 2021	SELL	$78.68 - $90.67 $6,294 - $7,253	-80 Reduced 0.96%	8,271 $692,000
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $2,867 - $3,649	-40 Reduced 0.48%	8,351 $761,000
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $79,821 - $103,878	1,188 Added 16.49%	8,391 $670,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $267,043 - $357,124	4,641 Added 181.15%	7,203 $497,000
Q1 2020 May 08, 2020	SELL	$52.41 - $81.0 $18,657 - $28,836	-356 Reduced 12.2%	2,562 $483,000
Q4 2019 Feb 11, 2020	BUY	$71.7 - $82.09 $2,724 - $3,119	38 Added 1.32%	2,918 $680,000
Q3 2019 Oct 24, 2019	SELL	$61.55 - $75.43 $7,693 - $9,428	-125 Reduced 4.16%	2,880 $634,000
Q2 2019 Aug 15, 2019	BUY	$55.74 - $64.41 $23,689 - $27,374	425 Added 16.47%	3,005 $555,000
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $95 - $128	2 Added 0.08%	2,580 $494,000
Q3 2018 Nov 15, 2018	SELL	$45.7 - $58.03 $914 - $1,160	-20 Reduced 0.77%	2,578 $449,000
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $3,905 - $4,719	92 Added 3.67%	2,598 $378,000
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $5,206 - $6,643	-140 Reduced 5.29%	2,506 $350,000
Q4 2017 Feb 15, 2018	BUY	$33.79 - $39.39 $89,408 - $104,225	2,646	2,646 $298,000

Others Institutions Holding EW

# of Institutions

1,369

Shares Held

469M

Call Options Held

2.45M

Put Options Held

2.66M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $42.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Account

Bryn Mawr Trust CO Edwards Lifesciences Corp Transaction History